DeciBio Launches Discovery Portals for Analysis and Visualization of Life Science Research Trends and Stakeholders

SANTA MONICA, Calif., Jan. 8, 2018 /PRNewswire/ -- DeciBio Consulting, LLC announced today the launch of their Discovery Portal line of data analysis and visualization tools. Discovery Portals leverage data aggregated from public and private databases such as PubMed, CMS, Federal RePORTER to track, segment, and prioritize life science researchers. These insights help users target ideal customers, maximize KOL collaborations, predict emerging market trends, benchmark sales forces, and obtain real-time customer updates.

"We have created similar custom sales-oriented tools in the past, and clients have had great success with those tools to get their product in front of the right customers and influencers," says David Cavanaugh, Partner at DeciBio. "We're proud to offer these new Discovery Portals to a broader audience and help innovative and disruptive technologies gain traction in the market."

The life science research tools market is estimated to be ~$50B. This market overall is expected to grow at roughly 5% annually, with specific sub-segments experiencing double-digit growth. Specific technologies (e.g., digital PCR) or applications for some customers (e.g., non-IVD clinical sequencing) are especially primed for such growth.

"The research tools space is constantly evolving. Novel approaches such as liquid biopsies are creating formidable opportunities, with different technologies such as digital PCR or NGS battling for mindshare for specific applications such as therapy selection or monitoring," says Stephane Budel, Partner at DeciBio. "Discovery Portals help emerging players and established veterans alike understand and navigate this complex landscape."

Discovery Portals have utility for multiple decision-makers within life science research tool supplier organizations, including Sales and Commercialization (e.g., generating and prioritizing leads), Marketing (e.g., monitoring technology trends across research segments), Research and Development (e.g., identifying potential collaboration opportunities), and Business Development (e.g., identifying possible IP acquisitions). Initial Discovery Portal application areas include:

• Agriculture Technology (AgBio)
• Clinical Oncology & Sequencing
• CRISPR
• Digital PCR (dPCR)
• Human Identification and forensics
• Human Microbiome
• Immuno-Oncology
• Life Science AI & Machine Learning
• Liquid Biopsies
• NGS: Nanopore Sequencing
• NGS: Long Reads
• Proteomics Research and Development
• Rare Diseases Research
• RNA interference (RNAi)
• Single Cell Genomics

The Discovery Portals are available now, and custom Discovery Portals can also be created by request for additional applications. For more information, visit https://www.decibio.com/decibiodiscovery/ or contact us for a demonstration.

About DeciBio Consulting
DeciBio Consulting, LLC is a strategy consulting and market intelligence firm based in Santa Monica, CA. DeciBio's mission is to provide the life sciences market intelligence and strategic insights that drive disruption and innovation in the research tools, clinical diagnostics, health technology, and adjacent markets. In addition to bespoke strategy consulting services, DeciBio offers market assessment reports, market data sets, and competitive intelligence tools. To learn more, visit https://www.decibio.com/.

Contact
DeciBio Consulting, LLC
(310) 451-4510
[email protected]

SOURCE DeciBio Consulting, LLC